• ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR

  2026-05-26

  This study reports a combinatorial library of reactive oxygen species (ROS)-degradable lipid nanoparticles engineered for selective mRNA delivery to tumor cells. By exploiting elevated ROS levels in cancer cells, the work demonstrates improved specificity and efficacy of mRNA therapeutics, with significant implications for targeted cancer treatment and gene modulation.

• TAK-242 (Resatorvid): Precision TLR4 Inhibition in Neuroinfl

  2026-05-25

  TAK-242 (Resatorvid) from APExBIO offers nanomolar-selective, pathway-specific blockade of TLR4 signaling, empowering researchers to dissect neuroinflammatory and autoimmune mechanisms with unprecedented specificity. This guide demystifies practical workflows, advanced applications, and troubleshooting strategies to unlock the full experimental potential of TAK-242 in both cell-based and in vivo models.

• (-)-JQ1: Gold-Standard Inactive Control for BET Bromodomains

  2026-05-25

  (-)-JQ1 is the JQ1 stereoisomer that serves as a rigorously validated inactive control for BET bromodomain inhibition. Its use in epigenetics research and cancer biology ensures specificity in BRD4-dependent cell line studies, enabling robust mechanistic dissection of transcriptional regulation.

• Starvation Drives Autophagy–Apoptosis Switch via ER-Ca2+-Cal

  2026-05-24

  This study uncovers how starvation triggers a regulated transition from autophagy to apoptosis in the Bombyx mori fat body through the ER-Ca2+-calpain signaling axis. By demonstrating the central role of IP3R-mediated calcium release and its pharmacological inhibition, the research provides mechanistic insights into programmed cell death under nutritional stress.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody for Reliable Immunod

  2026-05-23

  This article addresses common laboratory challenges in cell viability and pulmonary toxicology assays, demonstrating how HRP Rabbit Anti-Goat IgG (H+L) Antibody (SKU K1224) from APExBIO provides reproducible, high-sensitivity detection of goat primary antibodies. Scenario-driven Q&A illustrates its advantages in workflow optimization and data reliability.

• Recent Advances in Ibuprofen Synthesis and COX Inhibition Re

  2026-05-22

  Ha and Paek's review elucidates how recent synthetic advances, including asymmetric and continuous-flow methodologies, have improved the efficiency and selectivity of ibuprofen and naproxen production. These innovations not only enable access to pharmacologically relevant enantiomers, such as (S)-(+)-Ibuprofen, but also support more rigorous inflammation pathway research.

• DHEA in Translational Research: Mechanisms and Strategic Imp

  2026-05-22

  This thought-leadership piece explores the mechanistic and translational value of Dehydroepiandrosterone (DHEA) in neural and ovarian research. Integrating new insights from PCOS models, it offers protocol guidance and strategic context for researchers aiming to maximize DHEA’s impact in neuroprotection, apoptosis inhibition, and granulosa cell biology.

• Anti-Fibrotic Action of 1-Phenyl-2-Pentanol in Hepatic Stell

  2026-05-21

  A recent study demonstrates that 1-Phenyl-2-pentanol, isolated from Moringa oleifera, attenuates liver fibrosis by downregulating key fibrotic markers and modulating the TGF-β1 and Wnt/β-catenin signaling pathways in hepatic stellate cells. These findings highlight its mechanistic potential for anti-fibrotic drug development and provide a foundation for further gastrointestinal and hepatobiliary research.

• HIF1α/PRDX1 Axis Orchestrates Mitochondrial Remodeling in PH

  2026-05-21

  This study uncovers a novel mechanism by which hypoxia-induced HIF1α transcriptionally upregulates PRDX1, promoting pulmonary vascular remodeling via DRP1 deSUMOylation and mitochondrial fragmentation. The findings position PRDX1 as a promising, redox-independent target for therapeutic intervention in pulmonary hypertension.

• Bufuralol (hydrochloride): Reliable β-Adrenergic Modulation

  2026-05-20

  This article explores real-world challenges in cell viability and pharmacokinetic assays, demonstrating how Bufuralol (hydrochloride) (SKU C5043) delivers reliable, reproducible results where traditional β-adrenergic antagonists fall short. Scenario-driven analysis highlights its validated use in hiPSC-derived organoid models, with practical guidance for experimental design, data interpretation, and vendor selection.

• Embryonic SAG Exposure Disrupts Tongue Development in Mice

  2026-05-20

  This study demonstrates that overactivation of Hedgehog signaling via Smoothened Agonist (SAG) at a critical embryonic stage impairs tongue muscle formation and midline fusion in mice, leading to cleft tongue malformations. The findings provide mechanistic insight into how excessive Hedgehog pathway activity perturbs craniofacial morphogenesis.

• Bedaquiline as a Diarylquinoline Antibiotic: Optimized Workf

  2026-05-19

  Bedaquiline elevates both tuberculosis and cancer research with its dual action on bacterial ATP synthase and cancer stem cell metabolism. This article details experimental setup, troubleshooting, and advanced use-cases, integrating host-directed therapy insights for multi-drug resistant tuberculosis and beyond.

• Bufuralol (hydrochloride) in β-Adrenergic Modulation: Lab Be

  2026-05-19

  This article addresses practical laboratory challenges in β-adrenergic modulation studies using Bufuralol (hydrochloride) (SKU C5043). Through scenario-driven Q&A blocks, we evaluate experimental reproducibility, compatibility with advanced models, and vendor selection, providing actionable guidance for cardiovascular pharmacology research. Laboratory scientists will find validated insights and protocol recommendations for deploying Bufuralol (hydrochloride) effectively.

• GSTA1 Drives Glutathione Depletion in α-Amanitin Hepatotoxic

  2026-05-18

  This study reveals a paradoxical role for GSTA1 in α-amanitin-induced liver injury: rather than providing protection, upregulated GSTA1 accelerates glutathione depletion and oxidative stress, intensifying hepatotoxicity. The findings refocus attention on GSTA1 as a potential therapeutic target and diagnostic marker in acute toxic liver injury scenarios.

• N3-kethoxal: Precision Mapping of RNA and ssDNA Structures

  2026-05-18

  N3-kethoxal (3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one) enables high-resolution mapping of RNA and ssDNA accessibility in both in vitro and live-cell contexts. Discover how this versatile, azide-functionalized probe streamlines RNA secondary structure probing, genomic mapping, and protein-interaction assays, with actionable troubleshooting tips and protocol benchmarks for reproducible results.

553 records 17/37 page Previous Next First page 上5页 1617181920 下5页 Last page